Digoxin
- Product NDC
- 0615-0547
- 11-digit product format
- 006150547
- Labeler code
- 0615
- Product ID
- 0615-0547_f002a62a-bf93-4ec8-b88a-91683b3e19ce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Digoxin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA077002
- Marketing category
- ANDA
- Marketing start
- 2007-10-30
- Marketing end
- 0000-00-00
- Substance
- DIGOXIN
- Active strength
- 0 mg/1
- Pharmacologic classes
- Cardiac Glycoside [EPC],Cardiac Glycosides [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-0547-05 | 2022-11-09 | C162847 | 48780-1 | 9d75b9d0-96c7-f424-e053-dadaa90a57ce | 2e75d6fc-9c0c-4520-9e52-3f668ccd815a |
| 0615-0547-31 | 2022-11-09 | C162847 | 48780-1 | 9d75b9d0-96c7-f424-e053-dadaa90a57ce | 2e75d6fc-9c0c-4520-9e52-3f668ccd815a |
| 0615-0547-39 | 2022-11-09 | C162847 | 48780-1 | 9d75b9d0-96c7-f424-e053-dadaa90a57ce | 2e75d6fc-9c0c-4520-9e52-3f668ccd815a |
| 0615-0547-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-96c7-f424-e053-dadaa90a57ce | 2e75d6fc-9c0c-4520-9e52-3f668ccd815a |
| 0615-0547-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-96c7-f424-e053-dadaa90a57ce | 2e75d6fc-9c0c-4520-9e52-3f668ccd815a |
| 0615-0547-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-96c7-f424-e053-dadaa90a57ce | 2e75d6fc-9c0c-4520-9e52-3f668ccd815a |